covid-19 testing pandemic patient

Covid-19: Synairgen embraces virtual clinical trials

Reading now: 996
www.pharmaceutical-technology.com

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The Covid-19 pandemic has significantly upset clinical development.

More than 1,000 clinical trials have been disrupted by the ongoing pandemic, primarily due to issues with enrolment and recruitment, according to GlobalData.

With many countries implementing nationwide lockdowns, it has become virtually impossible for patients to actually visit sites for monitoring.

To ease this burden, many companies have attempted to adapt and salvage their clinical trials by virtualising them, as this allows for remote monitoring of patients and a reduced need for participants to risk moving around during a pandemic.

Read more on pharmaceutical-technology.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA